• Company Type For Profit
  • Contact Email info@sonexa.com
  • Phone Number 858-356-6250
Sonexa Therapeutics, Inc., a pharmaceutical company, engages in the development of therapeutics drugs for the treatment of Alzheimer's disease and related disorders. It develops ST101, a small and orally active molecule compound that penetrates the blood-brain-barrier. The company was incorporated in 2007 and is based in San Diego, California.

Lists Featuring This Company

Closed United States Pharmaceutical Companies
786 Number of Organizations • $23.7B Total Funding Amount • 1,427 Number of Investors
Domain Associates Portfolio Companies
153 Number of Organizations • $20.4B Total Funding Amount • 1,174 Number of Investors
Closed United States Biotechnology Companies
2,257 Number of Organizations • $65.8B Total Funding Amount • 4,736 Number of Investors
Closed Pharmaceutical Companies
1,385 Number of Organizations • $34.2B Total Funding Amount • 1,996 Number of Investors

Frequently Asked Questions

Where is Sonexa Therapeutics's headquarters? Sonexa Therapeutics is located in San Diego, California, United States.Who invested in Sonexa Therapeutics? Sonexa Therapeutics has 5 investors including AgeChem Venture Fund and Mitsubishi International Corporation (MIC).How much funding has Sonexa Therapeutics raised to date? Sonexa Therapeutics has raised .When was the last funding round for Sonexa Therapeutics? Sonexa Therapeutics closed its last funding round on Aug 2, 2012 from a Debt Financing round.